Unique localization of circulating tumor cells in patients with hepatic metastases.
暂无分享,去创建一个
N. Habib | J. Jacob | J. Stebbing | L. Jiao | Richard Szydlo | Justin Stebbing | Richard Szydlo | R. Coombes | C. Apostolopoulos | N. Johnson | N. Tsim | R Charles Coombes | Nagy A Habib | Long R Jiao | Christos Apostolopoulos | Jimmy Jacob | Natalia Johnson | Nicole Tsim
[1] S. Choi,et al. Clinical Outcomes of Hepatic Resection and Radiofrequency Ablation in Patients With Solitary Colorectal Liver Metastasis , 2008, Journal of clinical gastroenterology.
[2] K. McMasters,et al. Radiofrequency Ablation vs. Resection for Hepatic Colorectal Metastasis: Therapeutically Equivalent? , 2009, Journal of Gastrointestinal Surgery.
[3] W. Sauerbrei,et al. Reporting recommendations for tumor marker prognostic studies (REMARK). , 2005, Journal of the National Cancer Institute.
[4] E. Yagüe,et al. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. , 2009, Pharmacogenomics.
[5] Byung Soh Min,et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. , 2009, American journal of surgery.
[6] R. Coombes,et al. Response of circulating tumor cells to systemic therapy in patients with metastatic breast cancer: comparison of quantitative polymerase chain reaction and immunocytochemical techniques. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] U. Neumann,et al. Open Surgical is Superior to Percutaneous Access for Radiofrequency Ablation of Hepatic Metastases , 2009, World Journal of Surgery.
[8] Dongil Choi,et al. Comparing the Outcomes of Radiofrequency Ablation and Surgery in Patients With a Single Small Hepatocellular Carcinoma and Well-Preserved Hepatic Function , 2005, Journal of clinical gastroenterology.
[9] M. Koch,et al. Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination – prospective randomized multicenter trial , 2008, BMC surgery.
[10] Leon W.M.M. Terstappen,et al. Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer , 2006, Clinical Cancer Research.
[11] M. Lorenz,et al. Impact of laparoscopic colonic resection on tumour growth and spread in an experimental model , 1999, The British journal of surgery.
[12] M. Dowsett,et al. Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques , 2005, British Journal of Cancer.
[13] A. Zaniboni,et al. Molecular signature detection of circulating tumor cells using a panel of selected genes. , 2008, Cancer letters.
[14] J. Stebbing,et al. Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear. , 2008, Future oncology.
[15] M. Beckmann,et al. Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: The German SUCCESS-Trial , 2008 .
[16] J. Stebbing,et al. New biomarkers in breast cancer: microRNAs and leptins--where are we now? , 2007, Biomarkers in medicine.
[17] R C Coombes,et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment , 2008, British Journal of Cancer.
[18] Katharina Pachmann,et al. Standardized quantification of circulating peripheral tumor cells from lung and breast cancer , 2005, Clinical chemistry and laboratory medicine.
[19] Real-time RT–PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer , 2006, British Journal of Cancer.
[20] N. Gusani,et al. Survival Outcomes of Patients with Colorectal Liver Metastases Following Hepatic Resection or Ablation in the Era of Effective Chemotherapy , 2009, Annals of Surgical Oncology.
[21] Alison Stopeck,et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] M. Fakih. Carcinoembryonic antigen monitoring in metastatic colorectal cancer: words of caution. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Alison Stopeck,et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.
[24] M. Molinari,et al. Hepatic resection versus radiofrequency ablation for hepatocellular carcinoma in cirrhotic individuals not candidates for liver transplantation: a Markov model decision analysis. , 2009, American journal of surgery.
[25] I. Vlachonikolis,et al. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] T. Kroll,et al. Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] M. Choti,et al. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. , 2008, Archives of surgery.
[28] D. Jäger,et al. [Systemic therapy for colorectal cancer]. , 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[29] M. Lorenz,et al. Impact of laparoscopic surgery on experimental hepatic metastases , 2001, The British journal of surgery.
[30] P. Farmer,et al. Synthesis and analysis of DNA adducts of arylamines. , 1996, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[31] Georgios Giamas,et al. Clinical significance of circulating tumor cells. , 2007, Biomarkers in medicine.